ICYMI, this week we had stories on the newest FDA approvals, biologic therapy in plaque psoriasis, and more.
Experts reflect on the treatment of patients with plaque psoriasis during the COVID-19 pandemic.
Closing out their discussion on the management of plaque psoriasis, panelists share their excitement for future directions in care.
James Del Rosso, DO, and Neal Bhatia, MD, provide an overview of JAK inhibitors for the treatment of atopic dermatitis.
This week's edition of the Mainstream Patients features stories about the benefits of castor oil, the controversy of fragranced skin care, and more.
Allergan Aesthetics, an AbbVie company, announced the FDA approval of Juvéderm Volbella XC for undereye hollows.
In this week’s Pointers with Dr Portela, the 208SkinDoc highlights a growing issue of lasers made to look like or mimic the technology of already approved lasers but can have dangerous consequences.
Tralokinumab-ldrm (Adbry; LEO Pharma) showed improvement in itch, sleep, anxiety, depression, and overall quality of life data for adolescent AD patients in newly released study data.
Medical networks and smaller practices alike are facing spiraling inflation costs and staffing shortfalls due to waves of COVID cases that are impacting physicians, staff, and management.
Two letters ask that pandemic-era flexibilities become permanent.
If approved, dupilumab will be the first biologic medicine available in the US to treat uncontrolled moderate to severe atopic dermatitis for young children 6 months to 5 years old.
The American Society for Dermatologic Surgery investigated how the COVID-19 pandemic affected both dermatology practices and patients from staffing reductions to telehealth.
The American Academy of Dermatology’s newest guideline focuses on awareness of other health conditions associated with atopic dermatitis in adult patients.
The results from the American Academy of Facial Plastic and Reconstructive Surgery annual survey showed an uptick in demand for facial plastic surgery, an increase in popularity for lifts and lasers, and a growing gender neutrality in patients.